Envisagenics

Long Island City, United States

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

$25.0M raised

Jun 2024

Series B

Top Investors

MadronaBristol-Myers SquibbNational Institutes of HealthRed Cell PartnersSV Angel

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Envisagenics raised?

Envisagenics has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in June 2024.

Who are Envisagenics's investors?

Envisagenics's investors include Madrona, Bristol-Myers Squibb, National Institutes of Health, Red Cell Partners, SV Angel.

Where is Envisagenics headquartered?

Envisagenics is headquartered in Long Island City, United States.

What does Envisagenics do?

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

What stage is Envisagenics at?

Envisagenics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 4, 2024.

MLA

"Envisagenics — Funding & Investors." VCBacked, June 4, 2024, https://www.vcbacked.co/company/envisagenics. Accessed June 4, 2026.

APA

VCBacked. (2024). Envisagenics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/envisagenics

Wikipedia (cite web)

{{cite web |title=Envisagenics — Funding & Investors |url=https://www.vcbacked.co/company/envisagenics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 4, 2024.